Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome

Arteriosclerosis Thrombosis and Vascular Biology(2020)10.1161/atvbaha.119.313775Source: DataRank Database

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome is a research paper published in Arteriosclerosis Thrombosis and Vascular Biology (2020). On theSindex it has a DataRank of 0. It has been cited 64 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access64 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.47)OA: bronzeTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Yan Ji ORCID,Drew J. Braet ORCID,Manisha Vadali,Ahmed A.M. Abdel‐Hamid ORCID,Cory D. Emal

Live enrichment

PubMed:32268785 PMC:PMC7255962 OpenAlex:https://openalex.org/W3015301814

NHLBI NIH HHS

Grant: P01 HL089407

NHLBI NIH HHS

Grant: R01 HL136746

NHLBI NIH HHS

Grant: R01 HL055374

BLRD VA

Grant: I01 BX005144

FWCI

2.47

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronze

journalhttps://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.119.313775

publisherhttps://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.119.313775

publisherhttps://www.ahajournals.org/doi/full/10.1161/ATVBAHA.119.313775

journalhttps://doi.org/10.1161/atvbaha.119.313775

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32268785

Fields of Study

Protease and Inhibitor MechanismsBlood Coagulation and Thrombosis MechanismsCalpain Protease Function and RegulationAnimalsAtherosclerosisCellular SenescenceDiet, WesternDisease Models, AnimalIndoleacetic AcidsMacrophagesMetabolic SyndromeMiceMice, KnockoutObesityPlaque, AtheroscleroticPlasminogen Activator Inhibitor 1Receptors, LDL

MeSH Terms

AnimalsDisease Models, AnimalIndoleacetic AcidsMacrophagesObesityReceptors, LDLCellular SenescencePlasminogen Activator Inhibitor 1Mice, KnockoutMetabolic SyndromeAtherosclerosisMicePlaque, AtheroscleroticDiet, Western

Keywords

Plasminogen activator inhibitor-1Metabolic syndromePlasminogen activatorDrugMedicineEndocrinologyInternal medicineObesityPharmacologyActivator (genetics)ReceptorAtherosclerosisFibrinolysisCellular senescenceMuscle, smooth

Sustainable Development Goals

SDG 0: Zero hunger

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome

FAIR Checklist

Authors (8)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)